Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease

被引:3
|
作者
De, Tanima [1 ]
Zhang, Honghong [1 ]
Alarcon, Cristina [1 ]
Lec, Bianca [1 ]
Avitia, Juan [1 ]
Smithberger, Erin [2 ]
Chen, Chuyu [1 ]
Horvath, Minnie [1 ]
Kwan, Sara [3 ]
Young, Mary [3 ]
Adhikari, Sarbani [3 ]
Kwon, John [2 ]
Pacheco, Jennifer [1 ]
Jarvik, Gail [4 ,5 ]
Wei, Wei-Qi [6 ]
Mentch, Frank [7 ]
Hakonarson, Hakon [7 ,8 ]
Sleiman, Patrick [7 ,8 ]
Gordon, Adam [1 ]
Harley, John [9 ,10 ]
Linneman, Jim [11 ]
Hebbring, Scott [12 ]
Parisiadou, Loukia [1 ]
Perera, Minoli A. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA
[2] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA
[3] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA
[4] Univ Washington, Dept Med Med Genet, Med Ctr, Seattle, WA 98195 USA
[5] Univ Washington, Med Ctr, Dept Genome Sci, Seattle, WA 98195 USA
[6] Vanderbilt Univ, Med Ctr, Biomed Informat, Nashville, TN USA
[7] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA
[8] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[9] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol CAGE, Cincinnati, OH 45229 USA
[10] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA
[11] Marshfield Clin Res Inst, Off Res Comp & Analyt, Marshfield, WI USA
[12] Marshfield Clin Res Inst, Ctr Precis Med Res, Marshfield, WI USA
关键词
anti-TNF alpha; genome-wide association study; inflammatory bowel disease; primary nonresponse; single-nucleotide polymorphism; GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; INFLIXIMAB; MANIFESTATIONS; POLYMORPHISMS; VARIANTS; DRUG; METAANALYSIS; IMPUTATION;
D O I
10.1097/FPC.0000000000000445
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives Primary nonresponse (PNR) to antitumor necrosis factor-alpha (TNF alpha) biologics is a serious concern in patients with inflammatory bowel disease (IBD). We aimed to identify the genetic variants associated with PNR. Patients and methods Patients were recruited from outpatient GI clinics and PNR was determined using both clinical and endoscopic findings. A case-control genome-wide association study was performed in 589 IBD patients and associations were replicated in an independent cohort of 293 patients. Effect of the associated variant on gene expression and TNF alpha secretion was assessed by cell-based assays. Pleiotropic effects were investigated by Phenome-wide association study (PheWAS). Results We identified rs34767465 as associated with PNR to anti-TNF alpha therapy (odds ratio: 2.07, 95% CI, 1.46-2.94, P = 2.43 x 10(-7), [replication odds ratio: 1.8, 95% CI, 1.04-3.16, P = 0.03]). rs34767465 is a multiple-tissue expression quantitative trait loci for FAM114A2. Using RNA-sequencing and protein quantification from HapMap lymphoblastoid cell lines (LCLs), we found a significant decrease in FAM114A2 mRNA and protein expression in both heterozygous and homozygous genotypes when compared to wild type LCLs. TNF alpha secretion was significantly higher in THP-1 cells [differentiated into macrophages] with FAM114A2 knockdown versus controls. Immunoblotting experiments showed that depletion of FAM114A2 impaired autophagy-related pathway genes suggesting autophagy-mediated TNF alpha secretion as a potential mechanism. PheWAS showed rs34767465 was associated with comorbid conditions found in IBD patients (derangement of joints [P = 3.7 x 10(-4)], pigmentary iris degeneration [P = 5.9 x 10(-4)], diverticulum of esophagus [P = 7 x 10(-4)]). Conclusions We identified a variant rs34767465 associated with PNR to anti-TNF alpha biologics, which increases TNF alpha secretion through mechanism related to autophagy. rs34767465 may also explain the comorbidities associated with IBD.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [1] Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy
    Miranda-Bautista, Jose
    de Gracia-Fernandez, Celia
    Lopez-Ibanez, Maria
    Barrientos, Maria
    Gallo-Molto, Alejandra
    Gonzalez-Arias, Marina
    Gonzalez-Gil, Casilda
    Diaz-Redondo, Alicia
    Marin-Jimenez, Ignacio
    Menchen, Luis
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (07) : 2130 - 2135
  • [2] Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease
    Strik, A. S.
    Bots, S. J. A.
    D'Haens, G.
    Lowenberg, M.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 429 - 439
  • [3] Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease
    Pouillon, Lieven
    Bossuyt, Peter
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (10) : 1277 - 1290
  • [4] AN AUDIT OF ADHERENCE TO ANTI-TNF THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Duncan, J.
    Sastrillo, M.
    Baker, J.
    Younge, L.
    Anderson, S.
    Lindsay, J.
    Sanderson, J.
    Irving, P.
    GUT, 2011, 60
  • [5] Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy
    José Miranda-Bautista
    Celia de Gracia-Fernández
    María López-Ibáñez
    María Barrientos
    Alejandra Gallo-Moltó
    Marina González-Arias
    Casilda González-Gil
    Alicia Díaz-Redondo
    Ignacio Marín-Jiménez
    Luis Menchén
    Digestive Diseases and Sciences, 2015, 60 : 2130 - 2135
  • [6] Cytomegalovirus, inflammatory bowel disease, and anti-TNFα
    Campos, Sara T.
    Portela, Francisco A.
    Tome, Luis
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (05) : 645 - 650
  • [7] Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy
    Khan, Nabeel
    Asim, Hamna
    Lichtenstein, Gary R.
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (12) : 1699 - 1708
  • [8] Endemic Fungal Infections in Inflammatory Bowel Disease Associated with Anti-TNF Antibody Therapy
    Ordonez, Miguel E.
    Farraye, Francis A.
    Di Palma, Jack A.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (11) : 2490 - 2500
  • [9] Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFα therapy
    D'Ovidio, Valeria
    Vernia, Piero
    Gentile, Giuseppe
    Capobianchi, Angela
    Marcheggiano, Adriana
    Viscido, Angelo
    Martino, Pietro
    Caprilli, Renzo
    JOURNAL OF CLINICAL VIROLOGY, 2008, 43 (02) : 180 - 183
  • [10] Inflammatory bowel disease and targeted oral anti-TNFα therapy
    Griffiths, Owen R.
    Landon, John
    Coxon, Ruth E.
    Morris, Keith
    James, Philip
    Adams, Rachel
    INFLAMMATORY DISORDERS, PT A, 2020, 119 : 157 - 198